Company: SMNR
Filing Date: 2025-07-02
Form Type: S-4/A
Source: 0001193125-25-154936
Chunk: 633

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-07-02
Form: S-4/A
Chunk 633
---
 redemptions” scenario), by:

| • |     | each person or “group” (as such term is used in Section 13(d)(3) of the Exchange Act) known by Denali to be the beneficial owner of more than 5% of shares of Denali Class A Ordinary Shares pre-Business Combination; |

| • |     | each person or “group” known by Denali who is expected to be the beneficial owner of more than 5% of New Semnur Common Stock immediately post-Business Combination; |

| • |     | each of Denali’s current executive officers and directors, and all current executive officers and directors of Denali as a group, in each case pre-Business Combination; and |

| • |     | each person who will become an executive officer or director of New Semnur, and all persons who will become executive officers and directors of New Semnur as a group, in each case pre-Business Combination. |

Beneficial ownership is determined according to the rules of the SEC, which generally provide that a person has beneficial ownership of a security if he, she or it possesses sole or shared voting or investment power over that security, including options and warrants that are currently exercisable or exercisable within 60 days. Unless otherwise indicated, Denali believes, based on information available to it, that all persons named in the table below have sole voting and investment power with respect to all Denali Ordinary Shares beneficially owned by them. The beneficial ownership of Denali Ordinary Shares pre-Business Combination is based on 2,616,239 Denali Ordinary Shares issued and outstanding as of May 30, 2025 (consisting of 29,117 Denali Class A Ordinary Shares, 14,622 Denali Class A Ordinary Shares underlying the Public Units, 510,000 Denali Private Placement Shares underlying the Denali Private Placement Units and 2,062,500 Denali Class B Ordinary Shares). The beneficial ownership of securities pre-Business Combination and post-Business Combination excludes the shares underlying the Public Warrants and the Denali Private Placement Warrants because those securities are not exercisable within 60 days of this proxy statement/prospectus. The expected beneficial ownership of New Semnur Common Stock and New Semnur Preferred Stock post-BusinessCombination set forth below reflects a “no redemptions” scenario and a “maximum redemptions” scenario.

| • |     | Under the “no redemptions” scenario, the expected beneficial